86 related articles for article (PubMed ID: 27156576)
1. Some leopards can change their spots: potential repositioning of stem cell reprogramming compounds as anti-cancer agents.
Kim WH; Shen H; Jung DW; Williams DR
Cell Biol Toxicol; 2016 Jun; 32(3):157-68. PubMed ID: 27156576
[No Abstract] [Full Text] [Related]
2. Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules.
Kang PJ; Moon JH; Yoon BS; Hyeon S; Jun EK; Park G; Yun W; Park J; Park M; Kim A; Whang KY; Koh GY; Oh S; You S
Biomaterials; 2014 Aug; 35(26):7336-45. PubMed ID: 24881998
[TBL] [Abstract][Full Text] [Related]
3. Dedifferentiation of lineage-committed cells by a small molecule.
Chen S; Zhang Q; Wu X; Schultz PG; Ding S
J Am Chem Soc; 2004 Jan; 126(2):410-1. PubMed ID: 14719906
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.
White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI
Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming and Stemness.
Laplane L
Perspect Biol Med; 2015; 58(2):229-46. PubMed ID: 26750604
[TBL] [Abstract][Full Text] [Related]
6. Novel approach to bis(indolyl)methanes: de novo synthesis of 1-hydroxyiminomethyl derivatives with anti-cancer properties.
Grosso C; Cardoso AL; Lemos A; Varela J; Rodrigues MJ; Custódio L; Barreira L; Pinho e Melo TM
Eur J Med Chem; 2015 Mar; 93():9-15. PubMed ID: 25644672
[TBL] [Abstract][Full Text] [Related]
7. Vemurafenib/dabrafenib and trametinib.
Rissmann R; Hessel MH; Cohen AF
Br J Clin Pharmacol; 2015 Oct; 80(4):765-7. PubMed ID: 25847075
[No Abstract] [Full Text] [Related]
8. 5-Nitro-5'hydroxy-indirubin-3'oxime is a novel inducer of somatic cell transdifferentiation.
Jung DW; Hong YJ; Kim SY; Kim WH; Seo S; Lee JE; Shen H; Kim YC; Williams DR
Arch Pharm (Weinheim); 2014 Nov; 347(11):806-18. PubMed ID: 25363410
[TBL] [Abstract][Full Text] [Related]
9. Purmorphamine activates the Hedgehog pathway by targeting Smoothened.
Sinha S; Chen JK
Nat Chem Biol; 2006 Jan; 2(1):29-30. PubMed ID: 16408088
[TBL] [Abstract][Full Text] [Related]
10. Reversine promotes porcine muscle derived stem cells (PMDSCs) differentiation into female germ-like cells.
Lv X; Zhu H; Bai Y; Chu Z; Hu Y; Cao H; Liu C; He X; Peng S; Gao Z; Yang C; Hua J
J Cell Biochem; 2012 Dec; 113(12):3629-42. PubMed ID: 22821411
[TBL] [Abstract][Full Text] [Related]
11. Purmorphamine increased adhesion, proliferation and expression of osteoblast phenotype markers of human dental pulp stem cells cultured on beta-tricalcium phosphate.
Rezia Rad M; Khojaste M; Hasan Shahriari M; Asgary S; Khojasteh A
Biomed Pharmacother; 2016 Aug; 82():432-8. PubMed ID: 27470382
[TBL] [Abstract][Full Text] [Related]
12. 5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities.
Song JH; Lee JE; Cho KM; Park SH; Kim HJ; Kim YC; Kim TS
Mol Carcinog; 2016 May; 55(5):611-21. PubMed ID: 25788004
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of novel bisindole derivatives bearing oximes moiety: identification of novel proapoptotic agents.
Qu HE; Huang RZ; Yao GY; Li JL; Ye MY; Wang HS; Liu L
Eur J Med Chem; 2015 May; 95():400-15. PubMed ID: 25841196
[TBL] [Abstract][Full Text] [Related]
14. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
Tran TC; Sneed B; Haider J; Blavo D; White A; Aiyejorun T; Baranowski TC; Rubinstein AL; Doan TN; Dingledine R; Sandberg EM
Cancer Res; 2007 Dec; 67(23):11386-92. PubMed ID: 18056466
[TBL] [Abstract][Full Text] [Related]
15. [Research progress of cell dedifferentiation induced by reversine].
Hu X; Zhang X; Zhou Y; Yu Y; Xu H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Sep; 26(9):1126-9. PubMed ID: 23057363
[TBL] [Abstract][Full Text] [Related]
16. Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface.
Li H; Xiao H; Lin L; Jou D; Kumari V; Lin J; Li C
J Med Chem; 2014 Feb; 57(3):632-41. PubMed ID: 24456369
[TBL] [Abstract][Full Text] [Related]
17. Indirubin 3'-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent.
Ichimaru Y; Saito H; Uchiyama T; Metori K; Tabata K; Suzuki T; Miyairi S
Bioorg Med Chem Lett; 2015 Apr; 25(7):1403-6. PubMed ID: 25765906
[TBL] [Abstract][Full Text] [Related]
18. The synthetic purine reversine selectively induces cell death of cancer cells.
Piccoli M; Palazzolo G; Conforti E; Lamorte G; Papini N; Creo P; Fania C; Scaringi R; Bergante S; Tringali C; Roncoroni L; Mazzoleni S; Doneda L; Galli R; Venerando B; Tettamanti G; Gelfi C; Anastasia L
J Cell Biochem; 2012 Oct; 113(10):3207-17. PubMed ID: 22615034
[TBL] [Abstract][Full Text] [Related]
19. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Anastasia L; Pelissero G; Venerando B; Tettamanti G
Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
[TBL] [Abstract][Full Text] [Related]
20. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
Shi J; Shen HM
Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
